Dauch Corp (DCH) stock

DCHNYSEMotor Vehicle Parts & AccessoriesFiscal year ends December 31

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026Score 7/3032% below fair value

$4.78−0.21 (-4.21%)

Close on Oct 30, 2026Market cap $1.14BP/E –Yield –

Earnings

Dauch's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report

Nov 6, 2026

Q3 FY2026 · estimated, before the open

Revenue, Q2 FY2026

$2.96B

+92.2% on a year earlier

Adjusted earnings per share, Q2 FY2026

$0.32

$0.21 a year earlier

Latest guidance

Raised

Aug 7, 2026 · 6 items

Quarterly results

Revenue and earnings per share from each of Dauch's earnings releases, newest first

Quarter	Reported	Revenue	YoY	EPS	Adj. EPS	Source
Q3 FY2026ended Sep 30, 2026	Nov 6, 2026Expected	–	–	–	–	–
Q2 FY2026ended Jun 30, 2026	Aug 7, 2026before the open	$2.96B	+92.2%	$0.00	$0.32	Release
Q1 FY2026ended Mar 31, 2026	May 8, 2026before the open	$2.38B	+68.8%	-$0.52	$0.34	Release
Q4 FY2025ended Dec 31, 2025	Feb 13, 2026before the open	$1.38B	0.0%	-$0.63	$0.07	Release
Q3 FY2025ended Sep 30, 2025	Nov 7, 2025before the open	$1.51B	+0.7%	$0.07	$0.16	Release
Q2 FY2025ended Jun 30, 2025	Aug 8, 2025before the open	$1.54B	-5.5%	$0.32	$0.21	Release
Q1 FY2025ended Mar 31, 2025	May 2, 2025before the open	$1.41B	-12.4%	$0.06	$0.09	Release
Q4 FY2024ended Dec 31, 2024	Feb 14, 2025before the open	$1.38B	-5.5%	-$0.12	-$0.06	Release
Q3 FY2024ended Sep 30, 2024	Nov 8, 2024before the open	$1.50B	-3.2%	$0.08	$0.20	Release
Q2 FY2024ended Jun 30, 2024	Aug 9, 2024before the open	$1.63B	+3.8%	$0.15	$0.19	Release
Q1 FY2024ended Mar 31, 2024	May 3, 2024before the open	$1.61B	+8.1%	$0.17	$0.18	Release
Q4 FY2023ended Dec 31, 2023	Feb 16, 2024before the open	$1.46B	+5.0%	-$0.16	-$0.09	Release
Q3 FY2023ended Sep 30, 2023	Nov 3, 2023before the open	$1.55B	+0.6%	-$0.15	-$0.11	Release
Q2 FY2023ended Jun 30, 2023	Aug 4, 2023before the open	$1.57B	+9.0%	$0.07	$0.12	Release
Q1 FY2023ended Mar 31, 2023	May 5, 2023before the open	$1.49B	+3.5%	-$0.04	-$0.01	Release
Q4 FY2022ended Dec 31, 2022	Feb 17, 2023before the open	$1.39B	+12.1%	$0.11	-$0.07	Release
Q3 FY2022ended Sep 30, 2022	Nov 4, 2022before the open	$1.54B	+27.3%	$0.22	$0.27	Release
Q2 FY2022ended Jun 30, 2022	Aug 5, 2022before the open	$1.44B	–	$0.19	$0.22	Release
Q1 FY2022ended Mar 31, 2022	May 6, 2022before the open	$1.44B	–	$0.01	$0.19	Release
Q4 FY2021ended Dec 31, 2021	Feb 11, 2022before the open	$1.24B	–	-$0.41	-$0.09	Release
Q3 FY2021ended Sep 30, 2021	Nov 5, 2021before the open	$1.21B	–	-$0.02	$0.15	Release
Q2 FY2021ended Jun 30, 2021	Jul 30, 2021before the open	–	–	–	–	Filing
Q1 FY2021ended Mar 31, 2021	May 7, 2021before the open	–	–	–	–	Filing
Q4 FY2020ended Dec 31, 2020	Feb 12, 2021before the open	–	–	–	–	Filing
Q3 FY2020ended Sep 30, 2020	Oct 30, 2020before the open	–	–	–	–	Filing
Q2 FY2020ended Jun 30, 2020	Jul 31, 2020before the open	–	–	–	–	Filing

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Current guidance

Dauch's latest outlook for periods it has not reported yet, compared with what it said before

Metric	Period	Guidance	Before	Change	Given
Sales	FY2026	$10.60B – $10.80B	$10.30B – $10.80B	Raised	Aug 7, 2026
Adjusted EBITDAnon-GAAP	FY2026	$1.36B – $1.43B	$1.30B – $1.43B	Raised	Aug 7, 2026
Full year 2026 targeted EBITDAGAAP	FY2026	$1.02B – $1.12B	–	New	Feb 13, 2026
Adjusted free cash flownon-GAAP	FY2026	$260.00M – $325.00M	$235.00M – $325.00M	Raised	Aug 7, 2026
Full year 2026 targeted Free Cash FlowGAAP	FY2026	-$115.00M – -$90.00M	–	New	Feb 13, 2026
Capital expenditures	FY2026	4.5% – 5%	4.5% – 5%	Reaffirmed	Aug 7, 2026
Net cash provided by operating activitiesGAAP	FY2026	$385.00M – $410.00M	–	New	Feb 13, 2026
Net incomeGAAP	FY2026	-$130.00M – -$60.00M	–	Lowered	Feb 13, 2026
Restructuring cash payments	FY2026	$115.00M – $150.00M	–	New	Aug 7, 2026
Synergy implementation cash payments	FY2026	$95.00M – $110.00M	–	Lowered	Aug 7, 2026

Guidance vs results

The last range Dauch gave before each report, against the figure it then reported. Full years add up the four quarters.

Period	Metric	Guidance	Actual	Result
FY2025	Revenue	$5.80B – $5.90B	$5.84BΣ4Q	Within range

Guidance history

Every forecast Dauch put in an earnings release, newest first

Given	Metric	Period	Guidance	Change
Aug 7, 2026	Capital expenditures	FY2026	4.5% – 5%	Reaffirmed
Aug 7, 2026	Adjusted EBITDA	FY2026	$1.36B – $1.43B	Raised
Aug 7, 2026	Adjusted free cash flow	FY2026	$260.00M – $325.00M	Raised
Aug 7, 2026	Synergy implementation cash payments	FY2026	$95.00M – $110.00M	Lowered
Aug 7, 2026	Restructuring cash payments	FY2026	$115.00M – $150.00M	New
Aug 7, 2026	Sales	FY2026	$10.60B – $10.80B	Raised
May 8, 2026	Capital expenditures	FY2026	4.5% – 5%	Reaffirmed
May 8, 2026	Adjusted EBITDA	FY2026	$1.30B – $1.43B	Raised
May 8, 2026	Adjusted free cash flow	FY2026	$235.00M – $325.00M	Reaffirmed
May 8, 2026	Sales	FY2026	$10.30B – $10.80B	Raised
Feb 13, 2026	Capital expenditures	FY2026	4.5% – 5%	New
Feb 13, 2026	Full year 2026 targeted EBITDA	FY2026	$1.02B – $1.12B	New
Feb 13, 2026	Adjusted EBITDA	FY2026	$1.30B – $1.40B	New
Feb 13, 2026	Full year 2026 targeted Free Cash Flow	FY2026	-$115.00M – -$90.00M	New
Feb 13, 2026	Adjusted free cash flow	FY2026	$235.00M – $325.00M	New
Feb 13, 2026	Net income	FY2026	-$130.00M – -$60.00M	Lowered
Feb 13, 2026	Net cash provided by operating activities	FY2026	$385.00M – $410.00M	New
Feb 13, 2026	Sales	FY2026	$10.30B – $10.70B	New
Nov 7, 2025	capital spending	FY2025	5%	New
Nov 7, 2025	Adjusted EBITDA	FY2025	$710.00M – $745.00M	New
Nov 7, 2025	Adjusted free cash flow	FY2025	$180.00M – $210.00M	New
Nov 7, 2025	sales	FY2025	$5.80B – $5.90B	New
Aug 8, 2025	capital spending	FY2025	5%	Reaffirmed
Aug 8, 2025	Adjusted EBITDA	FY2025	$695.00M – $745.00M	Raised
Aug 8, 2025	Adjusted free cash flow	FY2025	$175.00M – $215.00M	Raised
Aug 8, 2025	sales	FY2025	$5.75B – $5.95B	Raised
May 2, 2025	capital spending	FY2025	5%	Reaffirmed
May 2, 2025	Adjusted EBITDA	FY2025	$665.00M – $745.00M	Lowered
May 2, 2025	Adjusted free cash flow	FY2025	$165.00M – $215.00M	Lowered
May 2, 2025	sales	FY2025	$5.65B – $5.95B	Lowered
Feb 14, 2025	capital spending	FY2025	5%	New
Feb 14, 2025	Adjusted EBITDA	FY2025	$700.00M – $760.00M	New
Feb 14, 2025	Adjusted free cash flow	FY2025	$200.00M – $230.00M	New
Feb 14, 2025	sales	FY2025	$5.80B – $6.05B	New
Nov 8, 2024	capital spending	FY2024	4%	Reaffirmed
Nov 8, 2024	Adjusted EBITDA	FY2024	$715.00M – $745.00M	Narrowed
Nov 8, 2024	Adjusted free cash flow	FY2024	$200.00M – $220.00M	Lowered
Nov 8, 2024	sales	FY2024	$6.10B – $6.15B	New
Aug 9, 2024	capital spending	FY2024	4%	Lowered
Aug 9, 2024	Adjusted EBITDA	FY2024	$705.00M – $755.00M	Raised
Aug 9, 2024	Adjusted free cash flow	FY2024	$200.00M – $240.00M	Reaffirmed
Aug 9, 2024	sales	FY2024	$6.10B – $6.30B	Narrowed
May 3, 2024	capital spending	FY2024	4% – 4.5%	Reaffirmed
May 3, 2024	Adjusted EBITDA	FY2024	$685.00M – $750.00M	Reaffirmed
May 3, 2024	Adjusted free cash flow	FY2024	$200.00M – $240.00M	Reaffirmed
May 3, 2024	sales	FY2024	$6.05B – $6.35B	Reaffirmed
Feb 16, 2024	capital spending	FY2024	4% – 4.5%	New
Feb 16, 2024	Adjusted EBITDA	FY2024	$685.00M – $750.00M	New
Feb 16, 2024	Adjusted free cash flow	FY2024	$200.00M – $240.00M	New
Feb 16, 2024	sales	FY2024	$6.05B – $6.35B	New
Nov 3, 2023	capital spending	FY2023	3% – 3.5%	New
Nov 3, 2023	Adjusted EBITDA	FY2023	$660.00M – $685.00M	Lowered
Nov 3, 2023	Adjusted free cash flow	FY2023	$200.00M – $215.00M	Lowered
Nov 3, 2023	sales	FY2023	$6.00B – $6.10B	Narrowed
Aug 4, 2023	capital spending	FY2023	3.5% – 4%	Reaffirmed
Aug 4, 2023	Adjusted EBITDA	FY2023	$725.00M – $800.00M	Reaffirmed
Aug 4, 2023	Adjusted free cash flow	FY2023	$225.00M – $300.00M	Reaffirmed
Aug 4, 2023	sales	FY2023	$5.95B – $6.25B	Reaffirmed
May 5, 2023	capital spending	FY2023	3.5% – 4%	Reaffirmed
May 5, 2023	Adjusted EBITDA	FY2023	$725.00M – $800.00M	Reaffirmed
May 5, 2023	Adjusted free cash flow	FY2023	$225.00M – $300.00M	Reaffirmed
May 5, 2023	sales	FY2023	$5.95B – $6.25B	Reaffirmed
Feb 17, 2023	capital spending	FY2023	3.5% – 4%	New
Feb 17, 2023	Adjusted EBITDA	FY2023	$725.00M – $800.00M	New
Feb 17, 2023	Adjusted free cash flow	FY2023	$225.00M – $300.00M	New
Feb 17, 2023	sales	FY2023	$5.95B – $6.25B	New
Nov 4, 2022	capital spending	FY2022	3% – 3.5%	Lowered
Nov 4, 2022	Adjusted EBITDA	FY2022	$745.00M – $765.00M	Lowered
Nov 4, 2022	Adjusted free cash flow	FY2022	$300.00M	Lowered
Nov 4, 2022	sales	FY2022	$5.75B – $5.85B	Lowered
Aug 5, 2022	capital spending	FY2022	3.5% – 4%	Reaffirmed
Aug 5, 2022	Adjusted EBITDA	FY2022	$790.00M – $830.00M	Raised
Aug 5, 2022	Adjusted free cash flow	FY2022	$300.00M – $350.00M	Reaffirmed
Aug 5, 2022	sales	FY2022	$5.75B – $5.95B	Raised
May 6, 2022	capital spending	FY2022	3.5% – 4%	Reaffirmed
May 6, 2022	Adjusted EBITDA	FY2022	$785.00M – $830.00M	Lowered
May 6, 2022	Adjusted free cash flow	FY2022	$300.00M – $350.00M	Lowered
May 6, 2022	sales	FY2022	$5.60B – $5.80B	New
Feb 11, 2022	capital spending	FY2022	3.5% – 4%	New
Feb 11, 2022	Adjusted EBITDA	FY2022	$800.00M – $875.00M	New
Feb 11, 2022	Adjusted free cash flow	FY2022	$300.00M – $375.00M	New
Feb 11, 2022	sales	FY2022	$5.60B – $5.90B	New
Nov 5, 2021	Adjusted EBITDA	FY2021	$830.00M – $850.00M	New
Nov 5, 2021	Adjusted free cash flow	FY2021	$400.00M	New
Nov 5, 2021	sales	FY2021	$5.15B – $5.25B	New

Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.